Report cover image

Antimicrobial Suture Market By Type (Absorbable, Non absorbable) , By End User (Hospitals, Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Publisher Allied Market Research
Published Jul 01, 2024
Length 280 Pages
SKU # ALMR19230066

Description

Antimicrobial Suture Market By Type (Absorbable, Non absorbable) , By End User (Hospitals, Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033


Antimicrobial Suture Market
The antimicrobial suture market was valued at $297.9 million in 2023 and is projected to reach $430.1 million by 2033, growing at a CAGR of 3.7% from 2024 to 2033.
An antimicrobial suture is a medical stitch macerated with chemical compounds which are toxic to bacteria. It is applied on wounds to prevent the growth of bacteria and reduce the chances of infection. The action mechanism of the chemical compound present in antimicrobial sutures involves interrupting the cell mechanisms of bacteria. Different surgical procedures such as general surgeries, cardiovascular surgeries, and orthopedic surgeries involve the application of sutures for wound healing. The sutures are essential for patients with high risk of infection, with compromised immune systems, or those undergoing lengthy surgical procedures.
Increase in awareness about the risk of infection over wounds or surgical sites is enhancing the adoption of antimicrobial sutures, thereby driving the growth of the market. In addition, the frequency of surgical procedures is increasing due to rise in prevalence of chronic diseases, exponential growth of aging population, and upsurge in the availability of medical facilities. These factors are boosting the demand for antimicrobial sutures. Currently, the usage of nanoengineering in the production of sutures is acquiring traction as the technique enhances their antimicrobial properties. The technique is further being utilized to design biodegradable sutures.
However, the higher cost of antimicrobial sutures as compared to the conventional stitches restricts their adoption, particularly in the healthcare settings with low budgets. In addition, several healthcare providers prefer conventional sutures over the advanced antimicrobial sutures due to the familiarity with its application, hence restraining the development of the market. On the contrary, the development of innovative smart sutures with enhanced attributes is anticipated to present novel growth opportunities for the market. Engineers from the Massachusetts Institute of Technology have designed a smart suture which releases drugs upon the detection of inflammation, along with holding the tissue in place. Derived from animal tissues, the suture encloses hydrogel integrated with drugs, cells, or sensors, which release the therapeutic molecules when necessary.

Segment Review

The antimicrobial suture market is segmented into type, end user, and region. On the basis of type, the market is bifurcated into absorbable and non-absorbable. As per end user, it is divided into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the absorbable segment is expected to be the highest shareholder by 2033.
As per end user, the hospital segment dominated the market in 2023.
Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global antimicrobial suture market include W.L. Gore & Associates, Medtronic Inc., Johnson and Johnson, Sutures India Pvt Ltd., Lotus Surgicals, B. Braun Melsungen AG, Smith & Nephew plc, Boston Scientific Corporation, Demetech Corporation, and Conmed Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Key Market Segments

By Type

Absorbable
Non absorbable

By End User

Hospitals
Clinics
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
W.L. Gore & Associates
Medtronic Inc.,
Johnson and Johnson
Sutures India Pvt Ltd.
Lotus Surgicals
B. Braun Melsungen AG
Smith & Nephew plc
Boston Scientific Corporation
Demetech Corporation
Conmed Corporation

Table of Contents

280 Pages
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ANTIMICROBIAL SUTURE  MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Absorbable
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Non Absorbable
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ANTIMICROBIAL SUTURE  MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Clinics
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ANTIMICROBIAL SUTURE  MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Antimicrobial Suture  Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Antimicrobial Suture  Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Antimicrobial Suture  Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. France Antimicrobial Suture  Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. Germany Antimicrobial Suture  Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. Italy Antimicrobial Suture  Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Spain Antimicrobial Suture  Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. UK Antimicrobial Suture  Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Antimicrobial Suture  Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. China Antimicrobial Suture  Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. Japan Antimicrobial Suture  Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Antimicrobial Suture  Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Antimicrobial Suture  Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Antimicrobial Suture  Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Antimicrobial Suture  Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Antimicrobial Suture  Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. South Africa Antimicrobial Suture  Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. Saudi Arabia Antimicrobial Suture  Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Antimicrobial Suture  Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. W.L. Gore And Associates
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Medtronic Inc.,
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Johnson And Johnson
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Sutures India Pvt Ltd.
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Lotus Surgicals
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. B. Braun Melsungen AG
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Smith And Nephew Plc
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Boston Scientific Corporation
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Demetech Corporation
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Conmed Corporation
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 2. ANTIMICROBIAL SUTURE  MARKET FOR ABSORBABLE, BY REGION, 2024 - 2033 ($MILLION)
TABLE 3. ANTIMICROBIAL SUTURE  MARKET FOR NON ABSORBABLE, BY REGION, 2024 - 2033 ($MILLION)
TABLE 4. GLOBAL ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 5. ANTIMICROBIAL SUTURE  MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 6. ANTIMICROBIAL SUTURE  MARKET FOR CLINICS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 7. ANTIMICROBIAL SUTURE  MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 8. ANTIMICROBIAL SUTURE  MARKET, BY REGION, 2024 - 2033 ($MILLION)
TABLE 9. NORTH AMERICA ANTIMICROBIAL SUTURE  MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 10. NORTH AMERICA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 11. NORTH AMERICA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 12. U.S. ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 13. U.S. ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 14. CANADA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 15. CANADA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 16. MEXICO ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 17. MEXICO ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 18. EUROPE ANTIMICROBIAL SUTURE  MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 19. EUROPE ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 20. EUROPE ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 21. FRANCE ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 22. FRANCE ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 23. GERMANY ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 24. GERMANY ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 25. ITALY ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 26. ITALY ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 27. SPAIN ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 28. SPAIN ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 29. UK ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 30. UK ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 31. REST OF EUROPE ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 32. REST OF EUROPE ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 33. ASIA-PACIFIC ANTIMICROBIAL SUTURE  MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 34. ASIA-PACIFIC ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 35. ASIA-PACIFIC ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 36. CHINA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 37. CHINA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 38. JAPAN ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 39. JAPAN ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 40. INDIA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 41. INDIA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 42. SOUTH KOREA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 43. SOUTH KOREA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 44. AUSTRALIA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 45. AUSTRALIA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 46. REST OF ASIA-PACIFIC ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 48. LAMEA ANTIMICROBIAL SUTURE  MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 49. LAMEA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 50. LAMEA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 51. BRAZIL ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 52. BRAZIL ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 53. SOUTH AFRICA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 54. SOUTH AFRICA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 55. SAUDI ARABIA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 56. SAUDI ARABIA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 57. REST OF LAMEA ANTIMICROBIAL SUTURE  MARKET, BY TYPE, 2024 - 2033 ($MILLION)
TABLE 58. REST OF LAMEA ANTIMICROBIAL SUTURE  MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 59. W.L. GORE AND ASSOCIATES: KEY EXECUTIVES
TABLE 60. W.L. GORE AND ASSOCIATES: COMPANY SNAPSHOT
TABLE 61. W.L. GORE AND ASSOCIATES: OPERATING SEGMENTS
TABLE 62. W.L. GORE AND ASSOCIATES: PRODUCT PORTFOLIO
TABLE 63. W.L. GORE AND ASSOCIATES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64. MEDTRONIC INC., : KEY EXECUTIVES
TABLE 65. MEDTRONIC INC., : COMPANY SNAPSHOT
TABLE 66. MEDTRONIC INC., : OPERATING SEGMENTS
TABLE 67. MEDTRONIC INC., : PRODUCT PORTFOLIO
TABLE 68. MEDTRONIC INC., : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 70. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 71. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 72. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 73. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. SUTURES INDIA PVT LTD.: KEY EXECUTIVES
TABLE 75. SUTURES INDIA PVT LTD.: COMPANY SNAPSHOT
TABLE 76. SUTURES INDIA PVT LTD.: OPERATING SEGMENTS
TABLE 77. SUTURES INDIA PVT LTD.: PRODUCT PORTFOLIO
TABLE 78. SUTURES INDIA PVT LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. LOTUS SURGICALS: KEY EXECUTIVES
TABLE 80. LOTUS SURGICALS: COMPANY SNAPSHOT
TABLE 81. LOTUS SURGICALS: OPERATING SEGMENTS
TABLE 82. LOTUS SURGICALS: PRODUCT PORTFOLIO
TABLE 83. LOTUS SURGICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 85. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 86. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 87. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 88. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89. SMITH AND NEPHEW PLC: KEY EXECUTIVES
TABLE 90. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
TABLE 91. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
TABLE 92. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
TABLE 93. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 95. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 96. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 97. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 98. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. DEMETECH CORPORATION: KEY EXECUTIVES
TABLE 100. DEMETECH CORPORATION: COMPANY SNAPSHOT
TABLE 101. DEMETECH CORPORATION: OPERATING SEGMENTS
TABLE 102. DEMETECH CORPORATION: PRODUCT PORTFOLIO
TABLE 103. DEMETECH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. CONMED CORPORATION: KEY EXECUTIVES
TABLE 105. CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 106. CONMED CORPORATION: OPERATING SEGMENTS
TABLE 107. CONMED CORPORATION: PRODUCT PORTFOLIO
TABLE 108. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ANTIMICROBIAL SUTURE  MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ANTIMICROBIAL SUTURE  MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ANTIMICROBIAL SUTURE  MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANTIMICROBIAL SUTURE  MARKET
FIGURE 10. GLOBAL ANTIMICROBIAL SUTURE  MARKET SEGMENTATION, BY TYPE
FIGURE 11. ANTIMICROBIAL SUTURE  MARKET FOR ABSORBABLE, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 12. ANTIMICROBIAL SUTURE  MARKET FOR NON ABSORBABLE, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 13. GLOBAL ANTIMICROBIAL SUTURE  MARKET SEGMENTATION, BY END USER
FIGURE 14. ANTIMICROBIAL SUTURE  MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 15. ANTIMICROBIAL SUTURE  MARKET FOR CLINICS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 16. ANTIMICROBIAL SUTURE  MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 21. COMPETITIVE DASHBOARD
FIGURE 22. COMPETITIVE HEATMAP: ANTIMICROBIAL SUTURE  MARKET
FIGURE 23. TOP PLAYER POSITIONING, 2023
FIGURE 24. W.L. GORE AND ASSOCIATES: NET SALES, 2021-2023 ($MILLION)
FIGURE 25. W.L. GORE AND ASSOCIATES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. W.L. GORE AND ASSOCIATES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. MEDTRONIC INC., : NET SALES, 2021-2023 ($MILLION)
FIGURE 28. MEDTRONIC INC., : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. MEDTRONIC INC., : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($MILLION)
FIGURE 31. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. SUTURES INDIA PVT LTD.: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. SUTURES INDIA PVT LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. SUTURES INDIA PVT LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. LOTUS SURGICALS: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. LOTUS SURGICALS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. LOTUS SURGICALS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. B. BRAUN MELSUNGEN AG: NET SALES, 2021-2023 ($MILLION)
FIGURE 40. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SMITH AND NEPHEW PLC: NET SALES, 2021-2023 ($MILLION)
FIGURE 43. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 46. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. DEMETECH CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 49. DEMETECH CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. DEMETECH CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. CONMED CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 52. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us